News
| PPD Completes Acquisition of BioDuro (December 03, 2009) PPD has completed its acquisition of BioDuro, capitalizing on the tremendous growth in Asia Pacific. |
| PPD to Acquire BioDuro (November 19, 2009) PPD has signed an agreement to acquire BioDuro, expanding PPD's drug development capabilities in China. |
| Shipping Drug R&D Abroad (October 19, 2009) While major U.S. drug companies have been laying off employees, headcounts at contract pharmaceutical research firms in China – including BioDuro – as well as India and Eastern Europe have surged. |
| CROs Expand Business to Fight Crisis (July 03, 2009) Beijing-based CRO BioDuro and AstraZeneca announced a major deal to expand their research collaboration to optimise discovery research for respiratory and inflammation indications. |
| BioDuro to Work with Roche on Discovery Chemistry (April 8, 2009) Just weeks after expanding its relationship with AstraZeneca, BioDuro has been asked to help with Roche's discovery-phase R&D program. |
| AstraZeneca and BioDuro Expand Discovery Contract (March 25, 2009) BioDuro says AstraZeneca has expanded its relationship with the firm to include the optimization of discovery research operations focused on drugs for respiratory and inflammatory disease. |
| BioDuro and AstraZeneca Expand Collaboration to Optimize Discovery Research for Respiratory and Inflammation Indications (March 23, 2009) BioDuro and AstraZeneca announced today that they have expanded their research collaboration to optimize discovery research for respiratory and inflammation indications. |
| Fully Integrated Research Service Is the Future (April 1, 2009) The world is a different place now than it was three months ago or even six months ago. Even without the financial crisis that has crippled the global economy, the pharmaceutical industry was already in disarray as news of large layoffs from the major pharma spread across North America and Europe. |